Growth Metrics

INVO Fertility (IVF) Change in Account Payables (2011 - 2020)

INVO Fertility (IVF) reported Change in Account Payables of -$96566.0 for Q4 2020, down 166.44% year-over-year from $145345.0 in Q1 2020, and down 214.31% on a QoQ basis from $84480.0 in Q3 2020.

INVO Fertility (IVF) has 3 years of Change in Account Payables data on file, last reported at -$96566.0 in Q4 2020.

  • Quarterly Change in Account Payables fell 166.44% year-over-year to -$96566.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was -$61696.0 (down 168.71% YoY) and the FY2020 annual result came in at -$61696.0, down 168.71% from the prior year.
  • Change in Account Payables fell to -$96566.0 in Q4 2020 per IVF's latest filing, from $84480.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $145345.0 in Q4 2019 and bottomed at -$96566.0 in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -198.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 221.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 56.90 Mn
10 INVO Fertility 5.12 Mn 4.76 Mn 629,345.00 -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2020 -96,566.00
Dec 31, 2020 -96,566.00
Sep 30, 2020 84,480.00
Sep 30, 2020 84,480.00
Jun 30, 2020 -59,931.00
Jun 30, 2020 -59,931.00
Mar 31, 2020 10,321.00
Mar 31, 2020 10,321.00
Dec 31, 2019 145,345.00
Dec 31, 2019 145,345.00
Sep 30, 2019 -80,011.00
Sep 30, 2019 -80,011.00
Jun 30, 2019 24,458.00
Jun 30, 2019 24,458.00
Sep 30, 2011 -11,583.00
Sep 30, 2011 -11,583.00